Added to YB: 2024-06-13
Pitch date: 2024-06-13
SLS [bullish]
SELLAS Life Sciences Group, Inc.
+33.55%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States.
Market Cap
$94.5M
Pitch Price
$1.52
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.64
P/E
-2.06
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
SELLAS LIFE SCIENCES GROUP I SLS
A summary for this pitch has not been created yet.
Read full article (0 min)